Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of BRL 771.12 billion. The enterprise value is 1.04 trillion.
Market Cap | 771.12B |
Enterprise Value | 1.04T |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | Jul 24, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.92% |
Shares Change (QoQ) | -0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 13.09 and the forward PE ratio is 9.03.
PE Ratio | 13.09 |
Forward PE | 9.03 |
PS Ratio | 2.21 |
PB Ratio | 1.58 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of 15.21.
EV / Earnings | 17.59 |
EV / Sales | 3.01 |
EV / EBITDA | 7.43 |
EV / EBIT | 10.74 |
EV / FCF | 15.21 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.
Current Ratio | 1.16 |
Quick Ratio | 0.78 |
Debt / Equity | 0.70 |
Debt / EBITDA | 2.42 |
Debt / FCF | 4.99 |
Interest Coverage | 6.26 |
Financial Efficiency
Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.
Return on Equity (ROE) | 12.17% |
Return on Assets (ROA) | 5.25% |
Return on Invested Capital (ROIC) | 7.18% |
Return on Capital Employed (ROCE) | 10.53% |
Revenue Per Employee | 4.32M |
Profits Per Employee | 727,194 |
Employee Count | 81,000 |
Asset Turnover | 0.30 |
Inventory Turnover | 1.45 |
Taxes
Income Tax | -1.29B |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.39% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | -14.39% |
50-Day Moving Average | 33.83 |
200-Day Moving Average | 36.10 |
Relative Strength Index (RSI) | 51.08 |
Average Volume (20 Days) | 8,553 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, Pfizer had revenue of BRL 349.70 billion and earned 58.90 billion in profits. Earnings per share was 10.38.
Revenue | 349.70B |
Gross Profit | 258.14B |
Operating Income | 97.16B |
Pretax Income | 57.70B |
Net Income | 58.90B |
EBITDA | 134.25B |
EBIT | 97.16B |
Earnings Per Share (EPS) | 10.38 |
Balance Sheet
The company has 72.58 billion in cash and 339.90 billion in debt, giving a net cash position of -267.31 billion.
Cash & Cash Equivalents | 72.58B |
Total Debt | 339.90B |
Net Cash | -267.31B |
Net Cash Per Share | n/a |
Equity (Book Value) | 487.63B |
Book Value Per Share | 85.47 |
Working Capital | 32.74B |
Cash Flow
In the last 12 months, operating cash flow was 83.20 billion and capital expenditures -15.07 billion, giving a free cash flow of 68.14 billion.
Operating Cash Flow | 83.20B |
Capital Expenditures | -15.07B |
Free Cash Flow | 68.14B |
FCF Per Share | n/a |
Margins
Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.
Gross Margin | 73.82% |
Operating Margin | 27.78% |
Pretax Margin | 16.50% |
Profit Margin | 16.84% |
EBITDA Margin | 38.39% |
EBIT Margin | 27.78% |
FCF Margin | 19.49% |
Dividends & Yields
This stock pays an annual dividend of 1.65, which amounts to a dividend yield of 4.90%.
Dividend Per Share | 1.65 |
Dividend Yield | 4.90% |
Dividend Growth (YoY) | 11.81% |
Years of Dividend Growth | 1 |
Payout Ratio | 89.68% |
Buyback Yield | -0.92% |
Shareholder Yield | 3.98% |
Earnings Yield | 7.64% |
FCF Yield | 8.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 29, 2020. It was a forward split with a ratio of 4.
Last Split Date | Oct 29, 2020 |
Split Type | Forward |
Split Ratio | 4 |
Scores
Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.2 |
Piotroski F-Score | 8 |